← Leaderboards
Anuja Ghorpade
University Of Nebraska Medical Center
$11,383,660
Attributed
$12,363,035
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2005–17$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$12,363,035 · 8
By mechanism
R01$10,203,534 · 5
P01$991,326 · 1
P20$949,175 · 1
R21$219,000 · 1
Top collaborators
- Yuri Persidsky5 shared
Most similar at University Of Nebraska Medical Center
Same institution · by research overlap
- James Haorah$2,229,992
- Janee Gelineau-Van Waes$3,861,925
Others in their field
Top investigators on “Hiv-1”
- Barton F Haynes · Duke University$476,288,740
- Lawrence Corey · Fred Hutchinson Cancer Center$445,419,385
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$294,186,693
- Constance Ann Benson · University Of California, San Diego$272,046,180
- Peter B. Gilbert · Fred Hutchinson Cancer Center$173,010,936
- Dan H. Barouch · Fred Hutchinson Cancer Center$166,542,502
Research focus
Hiv-1BrainAstrocytesLeadNeuronsBrain TissueInsightMediatingResponseAreaRegulationSignal TransductionPlayPathway InteractionsIn VivoBaseCellsSchemeFutureNeuroinflammationInvestigationAstrogliosisInhibitor/AntagonistNeurologic
Grant awards (42)
Neuronal Survival, HIV-1 and Astrocyte-TIMP-1$414,368
R01 · FY2017 · NS · contact PI
Astrocyte-TAAR1 & METH in HAND$346,750
R01 · FY2017 · DA · contact PI
Targeting latent HIV Astroglial Reservoirs without Reactivation$219,000
R21 · FY2017 · MH · contact PI
Neuronal Survival, HIV-1 and Astrocyte-TIMP-1$414,368
R01 · FY2016 · NS · contact PI
Astrocyte-TAAR1 & METH in HAND$343,282
R01 · FY2016 · DA · contact PI
Health Disparities & sCD40L: Novel Biomarkers for HIV-1 Disease Progression$197,402
P20 · FY2016 · MD · contact PI
Neuronal Survival, HIV-1 and Astrocyte-TIMP-1$414,368
R01 · FY2015 · NS · contact PI
Astrocyte-TAAR1 & METH in HAND$346,750
R01 · FY2015 · DA · contact PI
Health Disparities & sCD40L: Novel Biomarkers for HIV-1 Disease Progression$197,402
P20 · FY2015 · MD · contact PI
Neuronal Survival, HIV-1 and Astrocyte-TIMP-1$425,868
R01 · FY2014 · NS · contact PI
Health Disparities & sCD40L: Novel Biomarkers for HIV-1 Disease Progression$197,402
P20 · FY2014 · MD · contact PI
Neuronal survival, HIV-1 and Astrocyte TIMP-1$381,248
R01 · FY2013 · NS · contact PI
Mechanisms and Interventions for Methamphetamine and HIV-1 Induced CNS Injury$375,392
R01 · FY2013 · DA
CXCL8-mediated glial cross-talk and neuroprotection in HIV-1 Dementia$342,144
R01 · FY2013 · MH · contact PI
Health Disparities & sCD40L: Novel Biomarkers for HIV-1 Disease Progression$184,572
P20 · FY2013 · MD · contact PI
Neuronal survival, HIV-1 and Astrocyte TIMP-1$395,212
R01 · FY2012 · NS · contact PI
Mechanisms and Interventions for Methamphetamine and HIV-1 Induced CNS Injury$392,989
R01 · FY2012 · DA
CXCL8-mediated glial cross-talk and neuroprotection in HIV-1 Dementia$178,200
R01 · FY2012 · MH · contact PI
Health Disparities & sCD40L: Novel Biomarkers for HIV-1 Disease Progression$172,397
P20 · FY2012 · MD · contact PI
Neuronal survival, HIV-1 and Astrocyte TIMP-1$395,357
R01 · FY2011 · NS · contact PI
Mechanisms and Interventions for Methamphetamine and HIV-1 Induced CNS Injury$394,978
R01 · FY2011 · DA
CXCL8-mediated glial cross-talk and neuroprotection in HIV-1 Dementia$356,400
R01 · FY2011 · MH · contact PI
Mechanisms and Interventions for Methamphetamine and HIV-1 Induced CNS Injury$397,160
R01 · FY2010 · DA
Neuronal survival, HIV-1 and Astrocyte TIMP-1$395,504
R01 · FY2010 · NS · contact PI
CXCL8-mediated glial cross-talk and neuroprotection in HIV-1 Dementia$360,000
R01 · FY2010 · MH · contact PI
Mechanisms and Interventions for Methamphetamine and HIV-1 Induced CNS Injury$398,232
R01 · FY2009 · DA
Neuronal survival, HIV-1 and Astrocyte TIMP-1$379,058
R01 · FY2009 · NS · contact PI
CXCL8-mediated glial cross-talk and neuroprotection in HIV-1 Dementia$360,000
R01 · FY2009 · MH · contact PI
Neuronal Survival, HIV-1 and Astrocyte-TIMP-1$283,805
R01 · FY2008 · NS · contact PI
Cells and Tissue Core$189,586
P01 · FY2007 · NS · contact PI
Neuronal Survival, HIV-1 and Astrocyte-TIMP-1$172,701
R01 · FY2007 · NS · contact PI
Neuronal Survival, HIV-1 and Astrocyte-TIMP-1$117,000
R01 · FY2007 · NS · contact PI
Neuronal Survival, HIV-1 and Astrocyte-TIMP-1$298,353
R01 · FY2006 · NS · contact PI
Cells and Tissue Core$199,945
P01 · FY2006 · NS · contact PI
Neuronal Survival, HIV-1 and Astrocyte-TIMP-1$285,969
R01 · FY2005 · NS
Astrocyte Activation, Fas Ligand and HIV-1 Dementia$209,475
R01 · FY2005 · NS
Cells and Tissue Core$200,485
P01 · FY2005 · NS
Astrocyte Activation, Fas Ligand and HIV-1 Dementia$209,475
R01 · FY2004 · NS
Cells and Tissue Core$200,655
P01 · FY2004 · NS
Astrocyte Activation, Fas Ligand and HIV-1 Dementia$209,475
R01 · FY2003 · NS
Cells and Tissue Core$200,655
P01 · FY2003 · NS
Astrocyte Activation, Fas Ligand and HIV-1 Dementia$209,653
R01 · FY2002 · NS